*Chicago Equity Partners LLC Maintains Stake in Johnson & Johnson (JNJ)

June 27, 2018 - By Michael Lund

Johnson & Johnson (NYSE:JNJ) Corporate LogoDuring 2018 Q1 the big money sentiment increased to 0.93. That’s change of 0.06, from 2017Q4’s 0.87. 63 investors sold all, 831 reduced holdings as JNJ ratio improved. 720 rose positions while 111 funds bought positions. Funds hold 1.71 billion shares thus 0.80% less from 2017Q4’s 1.72 billion shares. Citigroup Inc, New York-based fund reported 1.21M shs. Fred Alger Mngmt invested in 0.03% or 46,967 shs. Philadelphia accumulated 0.16% or 15,417 shs. Manufacturers Life Ins The, Ontario – Canada-based fund reported 7.08M shs. Veritas Mgmt (Uk) Limited owns 2,860 shs. Jane Street Grp Inc Limited Liability Corporation holds 0.02% or 66,386 shs in its capital. Ashfield Prtnrs Ltd Liability Corporation reported 108,434 shs or 1.81% of all its holdings. Pure Finance Advsr invested 0.1% of its capital in Johnson & Johnson (NYSE:JNJ). Cornerstone Advisors invested 1.13% of its capital in Johnson & Johnson (NYSE:JNJ). Huntington Steele Lc has invested 0.13% in Johnson & Johnson (NYSE:JNJ). Fruth Invest Mgmt holds 1.74% or 30,573 shs in its capital. Alpine Woods Capital Investors Ltd reported 122,077 shs stake. Premier Asset Limited Liability Corp reported 2,749 shs. Texas Yale Capital owns 39,785 shs or 0.44% of their US capital. Catawba Mngmt Va invested in 1.58% or 51,255 shs.

JNJ registered $20.17 million net activity with 0 buys and 1 sale since February 15, 2018.

In 2018Q1 SEC form is reported Chicago Equity Partners Llc’s holdings in Johnson & Johnson (JNJ) which was reduced by 9.45%. 30,800 shares were sold by Chicago Equity Partners Llc as the company’s stock declined 8.03% with the market. The major pharmaceuticals company reported $37.82 million value for the 2018Q1. Now the institutional investor is holding 295,086 shares, compared to the 325,886 from the previous quarter. $326.74 billion is the MC of Johnson & Johnson. JNJ touched $121.82 during the last trading session after $0.53 change.Johnson & Johnson has volume of 329,621 shares. Since June 27, 2017 JNJ has declined 4.75% and is downtrending. JNJ underperformed the S&P 500 by 17.32%.

According to a filing the Chicago Equity Partners Llc’s stake in Varian Med Sys Inc (NYSE:VAR) was upped by 124,360 shares to 148,100 shares valued at $18.16 million in 2018Q1. It manages about $10.49B and $3.13 billion US Long portfolio. For a total of 109,490 shares it increased its holding in Umb Finl Corp (NASDAQ:UMBF) by 95,985 shares in the quarter, and has risen its stake in Ralph Lauren Corp (NYSE:RL).

Investors wait Johnson & Johnson (NYSE:JNJ)’s quarterly earnings on July, 17., Faxor reports. EPS of $2.06 is 12.57 % up from 2017’s $1.83 EPS. In case of $2.06 EPS JNJ’s profit could hit $5.53B. Last quarter $2.06 EPS was reported. Analysts predicts 0.00 % EPS growth this quarter.

A couple more Johnson & Johnson (NYSE:JNJ) news were announced by: Forbes.com which released on June 20, 2018 “What Are Johnson & Johnson’s Key Sources Of Revenue?”, also Seekingalpha.com on June 20, 2018 announced “Buy Johnson & Johnson”, the next Seekingalpha.com is “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” on June 01, 2018. Fool.com has article titled “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks”.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

In total 10 analysts cover Johnson & Johnson (NYSE:JNJ). “Buy” rating has 5, “Sell” are 1, while 4 are “Hold”. (NYSE:JNJ) has 50% bullish analysts. With $170.0 highest and $110.0 lowest target, Johnson & Johnson has $143.50 average target or 17.80% above the current ($121.82) price. 19 are the (NYSE:JNJ)’s ratings reports on Jun 27, 2018 according to StockzIntelligence Inc. On Thursday, May 17 the firm has “Buy” rating by Leerink Swann given. On Wednesday, April 18 the stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Deutsche Bank. On Tuesday, February 6 the firm earned “Buy” rating by Wells Fargo. On Monday, February 26 Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating. Jefferies has “Buy” rating and $165.0 target. On Tuesday, April 10 the firm earned “Equal-Weight” rating by Morgan Stanley. On Friday, January 12 the rating was maintained by Wells Fargo with “Buy”. On Friday, April 13 Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating. Jefferies has “Buy” rating and $15300 target. On Tuesday, February 27 Citigroup maintained the shares of JNJ in report with “Neutral” rating. The company rating was maintained by Wells Fargo on Wednesday, April 18. On Tuesday, January 23 the firm earned “Sell” rating by BTIG Research.

Johnson & Johnson (NYSE:JNJ) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: